Previous Article | Next Article 
Antimicrobial Agents and Chemotherapy, June 2006, p. 2038-2041, Vol. 50, No. 6
0066-4804/06/$08.00+0 doi:10.1128/AAC.01574-05
Copyright © 2006, American Society for Microbiology. All Rights Reserved.
DNA Microarray for Detection of Macrolide Resistance Genes
Marco Cassone,1
Marco M. D'Andrea,2
Francesco Iannelli,1
Marco R. Oggioni,1
Gian Maria Rossolini,2 and
Gianni Pozzi1*
LAMMB,1
FIBIM, Sezione di Microbiologia, Dipartimento di Biologia Molecolare, Università di Siena, Siena, Italy2
Received 10 December 2005/
Returned for modification 26 January 2006/
Accepted 31 March 2006

ABSTRACT
A DNA microarray was developed to detect bacterial genes conferring
resistance to macrolides and related antibiotics. A database
containing 65 nonredundant genes selected from publicly available
DNA sequences was constructed and used to design 100 oligonucleotide
probes that could specifically detect and discriminate all 65
genes. Probes were spotted on a glass slide, and the array was
reacted with DNA templates extracted from 20 reference strains
of eight different bacterial species (
Streptococcus pneumoniae,
Streptococcus pyogenes,
Enterococcus faecalis,
Enterococcus faecium,
Staphylococcus aureus,
Staphylococcus haemolyticus,
Escherichia coli, and
Bacteroides fragilis) known to harbor
29 different macrolide resistance genes. Hybridization results
showed that probes reacted with, and only with, the expected
DNA templates and allowed discovery of three unexpected genes,
including
msr(SA) in
B. fragilis, an efflux gene that has not
yet been described for gram-negative bacteria.

INTRODUCTION
Resistance to macrolides and related antibiotics (
macrolides-
lincosamides-
streptogramins [MLS]) is of great concern because
these drugs are commonly used to treat many different infectious
syndromes and because this resistance is spreading among gram-positive
and gram-negative bacteria, including strains isolated from
life-threatening infections such as pneumonia, sepsis, endocarditis,
and meningitis. Different classes of genes coding for MLS resistance
have been described, and their nucleotide sequences are available
in public databases (
22). Although macrolide resistance is present
worldwide, patterns and mechanisms of resistance may vary widely
in different geographic areas, leading to different therapeutic
strategies for infective syndromes, such as community-acquired
pneumonia (
15,
16,
19).
Detection of single bacterial genes (e.g., antibiotic resistance genes or species-specific genes) in diagnostics and in epidemiological studies is typically carried out by PCR, whereas DNA microarrays have been developed to perform a large number of different hybridization experiments simultaneously on a single membrane or glass substrate. They are well-suited to comprehensively investigate and quantitatively compare the expression levels of a large number of genes, but they can also be easily used in qualitative studies to detect selected DNA sequences (7, 8, 21). To assist epidemiological studies on the genetics of macrolide resistance in clinical isolates, a method based on DNA microarrays was developed to comprehensively assess the presence of MLS genes in bacterial genomes.

MATERIALS AND METHODS
Database construction and probe design.
The sequences of MLS resistance genes were retrieved from public
databases and comparatively analyzed to avoid redundancy. The
file containing the selected sequences in multi-FASTA format
(
http://www.compbio.ox.ac.uk/faq/format_examples.shtml) was
used to generate a database to be searched by Array Designer
2.0 software (Premier Biosoft, Palo Alto, CA). Probes, 40 to
60 nucleotides in size, with a melting temperature of 83 ±
1°C, were designed to specifically target each gene of the
database. Oligonucleotide probes generated by the software were
checked for homology to unrelated sequences present in public
databases, and, when possible, two probes for each gene were
designed for the array.
Construction of microarray slides.
Oligonucleotide probes were synthesized by MWG Biotech (Munich, Germany), with a C6 amino linker to allow better binding to the slide. Epoxy-modified glass slides (Pan-Epoxy slides; MWG Biotech) and a four-head pin ring spotting apparatus (GMS 417 arrayer; Genetics MicroSystems, Woburn, MA) were used. Probes were spotted in at least three replicates at a concentration of 30 pmol/µl in 20% dimethyl sulfoxide and 0.1% Tween 20. Resulting spots had a diameter of 80 to 120 µm.
Template DNA extraction, labeling, and hybridization.
Genomic DNA was extracted from a 10-ml bacterial culture harvested in exponential phase, according to a published protocol (4). For staphylococci, 20 U of lysostaphin was added to the lysis solution. One microgram of template DNA, in a reaction volume of 25 µl, was labeled with the fluorescent cytosine analog Cy5 (Amersham Biosciences, Piscataway, NJ) by random priming using 40 U of Klenow DNA polymerase, with a Cy5/dCTP ratio of 1. Ten microliters of the labeled DNA was brought to a volume of 14 µl in hybridization buffer (3x SSC [1x SSC is 0.15 M NaCl plus 0.015 M sodium citrate], 30 mM HEPES, pH 8, 0.3% sodium dodecyl sulfate, 5x Denhardt's solution), containing tRNA of Saccharomyces cerevisiae (Sigma, St. Louis, Mo.) at 1.5 mg per ml. After 2 min of denaturation at 100°C and 10 min at room temperature, the 14-µl mix was layered on the slide and hybridized for 1 h at 55°C. Slides were washed twice for 5 min in 2x SSC-0.1% sodium dodecyl sulfate at 65°C and then twice for 5 min in 1x SSC at room temperature and twice for 5 min in 0.2x SSC.
Data analysis.
Microarray slides were read using a GMS 428 array scanner (Genetics MicroSystems, Woburn, MA). Data were acquired using GenePix Pro 5.0 software (Axon Instruments, Union City, CA) and managed with Microsoft Excel. For each spot, median pixel intensity was assessed, and background signal was subtracted. To control for congruity of results obtained with replicate spots of a probe, the mean fluorescence intensity and the standard deviation (intraprobe standard deviation) was calculated for each probe. If, for a probe, the intraprobe standard deviation was higher than the mean fluorescence intensity, hybridization results were considered negative. The standard deviation of the mean fluorescence intensity of all probes of the microarray was also calculated. A probe was considered positive when its fluorescence intensity was higher than the mean fluorescence intensity of all probes plus 1 standard deviation.
Bacterial strains.
We hybridized total DNA from 20 bacterial strains carrying reference MLS resistance genes (Table 1).

RESULTS AND DISCUSSION
Probes for macrolide resistance genes.
A database which included 65 nonredundant macrolide resistance
genes published in GenBank was selected (Tables
2 to
4). Genes
were identified by accession number, since in some cases two
or more genes with different sequences share the same name.
One hundred oligonucleotide probes were designed and spotted
on the microarray slide to allow differential detection of the
65 selected MLS genes. Probes for ribosomal methylation genes
and their positions in the coding sequence are reported in Table
2, probes for efflux genes in Table
3, and probes for genes
coding for esterases, nucleotidyltransferases, phosphotransferases,
acetyltransferases, and hydrolases in Table
4.
View this table:
[in this window]
[in a new window]
|
TABLE 4. Probes for genes coding for esterases, nucleotidyltransferases, phosphotransferases, acetyltransferases, and hydrolases
|
Microarray hybridization.
Microarray slides were tested by hybridizing DNA templates extracted
from 20 strains belonging to eight different species and known
to harbor 29 different MLS genes (Table
1). All of the probes
designed to be specific for the 29 MLS genes reacted with the
predicted DNA templates, allowing validation of a total of 48
probes (Table
5). Three unexpected results were also obtained:
(i) the DNA of
Bacteroides fragilis V503 reacted with probe
msrSA-31, (ii) the DNA of
Staphylococcus aureus BM12235 reacted
with probe vgaAv-39, and (iii) the DNA of
S. aureus BM4611 reacted
with probes ermC-19 and ermC-20 (Table
5).
Identification of additional MLS genes in control strains.
Microarray data indicating the presence of unexpected MLS genes
in control strains were confirmed by DNA sequencing of the entire
open reading frame, using templates obtained by PCR, as previously
described (
23). In
B. fragilis strain V503, carrying the methylase
gene
erm(FU), sequence data indicated the concomitant presence
of an efflux gene identical to
msr(SA) (100% identity at the
DNA level) of
S. aureus (GenBank accession no. AB013298). The
msr(SA) gene is considered typical of
Staphylococcus spp. and
has never been found in gram-negative bacteria. In
S. aureus strain BM12235, carrying the major facilitator streptogramin
efflux gene
vga(B) and the streptogramin acetyltransferase gene
vat(B), it was possible to identify also the presence of
vga(A)v,
an ATP-binding transporter gene which is commonly associated
with
vga(B) and
vat(B) (
11,
12). DNA sequence analysis showed
that
vga(A)v of BM12235 was essentially identical (99% identity
at the DNA level) to
vga(A)v of
S. aureus BM3327 (GenBank accession
no. AF186237). In
S. aureus strain BM4611, carrying the lincomycin
nucleotidyltranferase gene
lnu(A), an associated methylase gene
of the
erm(C) class was found, with up to 90% identity at the
nucleotide level with several
erm(C) genes present in GenBank.
Conclusions.
This work provides detailed information for construction of a simple and powerful tool to investigate the genetic basis of macrolide resistance in bacterial isolates. Careful analysis of DNA sequences deposited in public databases allowed compilation of a list of 65 bacterial genes encoding resistance to macrolides and related drugs. Oligonucleotide DNA microarrays designed to detect these 65 genes in bacterial genomes were produced and used to test a collection of strains carrying well-characterized MLS genes. Results provided both (i) validation of the microarray chip and (ii) proof of concept that the microarray approach is effective in detecting associations of MLS genes not necessarily inferred by the resistance phenotype. Unlike other DNA microarrays developed to detect the most common resistance genes (8, 21), this one, by its comprehensive approach, is well-suited for surveillance studies specific for MLS resistance, where characterization of the resistance genotype is sought. This DNA microarray could significantly contribute to molecular epidemiology studies by allowing simultaneous testing for the presence of known MLS genes and in particular could help to define and understand the clustering of different MLS genes in genetic elements and genomes.

ACKNOWLEDGMENTS
We thank Annalisa Pantosti for advice and all researchers listed
in Table
1 for kindly providing control strains.
The work was funded in part by grants from Istituto Superiore di Sanità, from the University of Siena (PAR), and from MIUR (FIRB, RBAU01X9TB).

FOOTNOTES
* Corresponding author. Mailing address: LAMMB, Università di Siena, Policlinico Le Scotte/V Lotto, Viale Bracci, 53100 Siena, Italy. Phone: 39 0577 233299. Fax: 39 0577 233334. E-mail:
pozzi{at}unisi.it.


REFERENCES
1 - Allignet, J., and N. El Solh. 1997. Characterization of a new staphylococcal gene, vgaB, encoding a putative ABC transporter conferring resistance to streptogramin A and related compounds. Gene 202:133-138.[CrossRef][Medline]
2 - Allignet, J., N. Liassine, and N. El Solh. 1998. Characterization of a staphylococcal plasmid related to pUB110 and carrying two novel genes, vatC and vgbB, encoding resistance to streptogramins A and B and similar antibiotics. Antimicrob. Agents Chemother. 42:1794-1798.[Abstract/Free Full Text]
3 - Arthur, M., D. Autissier, and P. Courvalin. 1986. Analysis of the nucleotide sequence of the ereB gene encoding the erythromycin esterase type II. Nucleic Acids Res. 14:4987-4999.[Abstract/Free Full Text]
4 - Ausubel, F. M., R. Brent, R. E. Kingston, D. D. Moore, J. G. Seidman, J. A. Smith, and K. Struhl. 1989. Current protocols in molecular biology, p. 12.0.1-12.2.10. Wiley Interscience, Hoboken, N.J.
5 - Brisson-Noel, A., and P. Courvalin. 1986. Nucleotide sequence of gene linA encoding resistance to lincosamides in Staphylococcus haemolyticus. Gene 43:247-253.[CrossRef][Medline]
6 - Brisson-Noel, A., P. Delrieu, D. Samain, and P. Courvalin. 1988. Inactivation of lincosaminide antibiotics in Staphylococcus. Identification of lincosaminide O-nucleotidyltransferases and comparison of the corresponding resistance genes. J. Biol. Chem. 263:15880-15887.[Abstract/Free Full Text]
7 - Call, D. R., M. K. Bakko, M. J. Krug, and M. C. Roberts. 2003. Identifying antimicrobial resistance genes with DNA microarrays. Antimicrob. Agents Chemother. 47:3290-3295.[Abstract/Free Full Text]
8 - Call, D. R., M. K. Borucki, and F. J. Loge. 2003. Detection of bacterial pathogens in environmental samples using DNA microarrays. J. Microbiol. Methods 53:235-243.[CrossRef][Medline]
9 - Del Grosso, M., F. Iannelli, C. Messina, M. Santagati, N. Petrosillo, S. Stefani, G. Pozzi, and A. Pantosti. 2002. Macrolide efflux genes mef(A) and mef(E) are carried by different genetic elements in Streptococcus pneumoniae. J. Clin. Microbiol. 40:774-778.[Abstract/Free Full Text]
10 - Halula, M. C., S. Manning, and F. L. Macrina. 1991. Nucleotide sequence of ermFU, a macrolide-lincosamide-streptogramin (MLS) resistance gene encoding an RNA methylase from the conjugal element of Bacteroides fragilis V503. Nucleic Acids Res. 19:3453.[Free Full Text]
11 - Haroche, J., J. Allignet, and N. El Solh. 2002. Tn5406, a new staphylococcal transposon conferring resistance to streptogramin A and related compounds including dalfopristin. Antimicrob. Agents Chemother. 46:2337-2343.[Abstract/Free Full Text]
12 - Haroche, J., A. Morvan, M. Davi, J. Allignet, F. Bimet, and N. El Solh. 2003. Clonal diversity among streptogramin A-resistant Staphylococcus aureus isolates collected in French hospitals. J. Clin. Microbiol. 41:586-591.[Abstract/Free Full Text]
13 - Katayama, J., H. Okada, K. O'Hara, and N. Noguchi. 1998. Isolation and characterization of two plasmids that mediate macrolide resistance in Escherichia coli: transferability and molecular properties. Biol. Pharm. Bull. 21:326-329.[Medline]
14 - Kuroda, M., T. Ohta, I. Uchiyama, T. Baba, H. Yusawa, I. Kobayashi, L. Cui, A. Oguchi, K. Aoki, Y. Nagai, J. Lian, T. Ito, M. Kanamori, H. Matsumaru, A. Maruyama, H. Murakami, A. Hosoyama, Y. Mizutani-Ui, N. K. Takahashi, T. Sawano, R. Inoue, C. Kaito, K. Sekimizu, H. Hirakawa, S. Kuhara, S. Goto, J. Yabuzaki, M. Kanehisa, A. Yamashita, K. Oshima, K. Turuya, C. Yoshino, T. Shiba, M. Hattori, N. Ogasawara, H. Hayashi, and K. Hiramatsu. 2001. Whole genome sequencing of methicillin-resistant Staphylococcus aureus. Lancet 357:1225-1240.[CrossRef][Medline]
15 - Lonks, J. R., J. Garau, and A. A. Medeiros. 2002. Implications of antimicrobial resistance in the empirical treatment of community-acquired respiratory tract infections: the case of macrolides. J. Antimicrob. Chemother. 50:87-92.[Abstract]
16 - Lynch, J. P., and R. Martinez. 2003. Clinical relevance of macrolide-resistant Streptococcus pneumoniae for community-acquired pneumonia. Clin. Infect. Dis. 34:S27-S46.
17 - Macrina, F. L., R. P. Evans, J. A. Tobian, D. L. Hartley, D. B. Clewell, and K. R. Jones. 1983. Novel shuttle plasmid vehicles for Escherichia-Streptococcus transgenic cloning. Gene 25:145-150.[CrossRef][Medline]
18 - Martin, B., G. Alloing, V. Mejean, and J. P. Claverys. 1987. Constitutive expression of erythromycin resistance mediated by the ermAM determinant of plasmid pAMß1 results from deletion of 5' leader peptide sequences. Plasmid 18:250-253.[CrossRef][Medline]
19 - Moellering, R. C., Jr., W. Craig, M. Edmond, D. J. Farrell, M. J. Ferraro, T. M. File, Jr., J. Klein, J. Lonks, J. P. Metlay, D. Sahm, and G. H. Talbot. 2002. Clinical and public health implications of macrolide-resistant Streptococcus pneumoniae. J. Chemother. 14:42-56.
20 - Noguchi, N., A. Emura, H. Matsuyama, K. O'Hara, M. Sasatsu, and M. Kono. 1995. Nucleotide sequence and characterization of erythromycin resistance determinant that encodes macrolide 2'-phosphotransferase I in Escherichia coli. Antimicrob. Agents Chemother. 39:2359-2363.[Abstract]
21 - Perreten, V., L. Vorlet-Fawer, P. Slickers, R. Ehricht, P. Kuhnert, and J. Frey. 2005. Microarray-based detection of 90 antibiotic resistance genes of gram-positive bacteria. J. Clin. Microbiol. 43:2291-2302.[Abstract/Free Full Text]
22 - Roberts, M. C., J. Sutcliffe, P. Courvalin, L. B. Jensen, J. Rood, and H. Seppala. 1999. Nomenclature for macrolide and macrolide-lincosamide-streptogramin B resistance determinants. Antimicrob. Agents Chemother. 43:2823-2830.[Free Full Text]
23 - Santagati, M., F. Iannelli, M. R. Oggioni, S. Stefani, and G. Pozzi. 2000. Characterization of a genetic element carrying the macrolide efflux gene mef(A) in Streptococcus pneumoniae. Antimicrob. Agents Chemother. 44:2585-2587.[Abstract/Free Full Text]
24 - Seoane, A., and J. M. Garcia Lobo. 2000. Identification of a streptogramin A acetyltransferase gene in the chromosome of Yersinia enterocolitica. Antimicrob. Agents Chemother. 44:905-909.[Abstract/Free Full Text]
25 - Seppälä, H., M. Skurnik, H. Soini, M. C. Roberts, and P. Huovinen. 1998. A novel erythromycin resistance methylase gene (ermTR) in Streptococcus pyogenes. Antimicrob. Agents Chemother. 42:257-262.[Abstract/Free Full Text]
26 - Soltani, M., D. Beighton, J. Philpott-Howard, and N. Woodford. 2001. Identification of vat(E-3), a novel gene encoding resistance to quinupristin-dalfopristin in a strain of Enterococcus faecium from a hospital patient in the United Kingdom. Antimicrob. Agents Chemother. 45:645-646.[Free Full Text]
27 - Werner, G., and W. Witte. 1999. Characterization of a new enterococcal gene, satG, encoding a putative acetyltransferase conferring resistance to streptogramin A compounds. Antimicrob. Agents Chemother. 43:1913-1914.
28 - Wirth, R., F. Y. An, and D. B. Clewell. 1986. Highly efficient protoplast transformation system for Streptococcus faecalis and a new Escherichia coli-S. faecalis shuttle vector. J. Bacteriol. 165:831-836.[Abstract/Free Full Text]
Antimicrobial Agents and Chemotherapy, June 2006, p. 2038-2041, Vol. 50, No. 6
0066-4804/06/$08.00+0 doi:10.1128/AAC.01574-05
Copyright © 2006, American Society for Microbiology. All Rights Reserved.